Preface | |
Authorized Generic Pharmaceuticals: Effects on Innovation | |
Authorized Generics: An Interim Report | |
Remarks of J. Thomas Rosch, Commissioner, Federal Trade Commission, before the World Generic Medicine Congress, Hearing on "Pay-for-Delay Settlements, Authorized Generics, & Follow-On Biologies: Thoughts on the How Competition Law Can Best Protect Consumer Welfare in the Pharmaceutical Context" | |
Federal R&D, Drug Discovery, & Pricing: Insights from the NIH-University-Industry Relationship | |
Pharmaceutical R&D & the Evolving Market for Prescription Drugs | |
Federal Taxation of the Drug Industry & Its Effects on New Drug Development | |
Pharmaceutical Patent Litigation Settlements: Implications for Competition & Innovation | |
FDA's Authority to Regulate Drug Compounding: A Legal Analysis | |
Promotional Spending for Prescription Drugs | |
Index | |
Table of Contents provided by Publisher. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.